Literature DB >> 28067536

History of erectile dysfunction as a predictor of poor physical performance after an acute myocardial infarction.

Leonida Compostella1,2, Caterina Compostella3, Li Van Stella Truong1, Nicola Russo1,2, Tiziana Setzu1, Sabino Iliceto2, Fabio Bellotto1,2.   

Abstract

Background Erectile dysfunction may predict future cardiovascular events and indicate the severity of coronary artery disease in middle-aged men. The aim of this study was to evaluate whether erectile dysfunction (expression of generalized macro- and micro-vascular pathology) could predict reduced effort tolerance in patients after an acute myocardial infarction. Patients and methods One hundred and thirty-nine male patients (60 ± 12 years old), admitted to intensive cardiac rehabilitation 13 days after a complicated acute myocardial infarction, were evaluated for history of erectile dysfunction using the International Index of Erectile Function questionnaire. Their physical performance was assessed by means of two six-minute walk tests (performed two weeks apart) and by a symptom limited cardiopulmonary exercise test (CPET). Results Patients with erectile dysfunction (57% of cases) demonstrated poorer physical performance, significantly correlated to the degree of erectile dysfunction. After cardiac rehabilitation, they walked shorter distances at the final six-minute walk test (490 ± 119 vs. 564 ± 94 m; p < 0.001); at CPET they sustained lower workload (79 ± 28 vs. 109 ± 34 W; p < 0.001) and reached lower oxygen uptake at peak effort (18 ± 5 vs. 21 ± 5 ml/kg per min; p = 0.003) and at anaerobic threshold (13 ± 3 vs.16 ± 4 ml/kg per min; p = 0.001). The positive predictive value of presence of erectile dysfunction was 0.71 for low peak oxygen uptake (<20 ml/kg per min) and 0.69 for reduced effort capacity (W-max <100 W). Conclusions As indicators of generalized underlying vascular pathology, presence and degree of erectile dysfunction may predict the severity of deterioration of effort tolerance in post-acute myocardial infarction patients. In the attempt to reduce the possibly associated long-term risk, an optimization of type, intensity and duration of cardiac rehabilitation should be considered.

Entities:  

Keywords:  Erectile dysfunction; cardiac rehabilitation; cardiopulmonary exercise test; myocardial infarction; physical performance; six-minute walk test

Mesh:

Year:  2017        PMID: 28067536     DOI: 10.1177/2047487316686434

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

1.  An Alternative Prediction Equation for Evaluation of Six-Minute Walk Distance in Stable Coronary Artery Disease Patients.

Authors:  Helena Lenasi; Ana Novak; Borut Jug; Edvin Dervišević; Damir Karpljuk; Mateja Videmšek; Maroje Sorić; Vedran Hadžić
Journal:  Front Physiol       Date:  2022-03-31       Impact factor: 4.566

2.  Silencing Nogo-B receptor inhibits penile corpus cavernosum vascular smooth muscle cell apoptosis of rats with diabetic erectile dysfunction by down-regulating ICAM-1.

Authors:  Yun Zhang; Wei Huo; Yan Wen; Hai Li
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

3.  Sexual health in Polish elderly men with coronary artery disease: importance, expectations, and reality.

Authors:  Lesław Rusiecki; Romuald Zdrojowy; Jana Gebala; Michał Rabijewski; Małgorzata Sobieszczańska; Ryszard Smoliński; Witold Pilecki; Wioletta Dziubek; Anna Janocha; Maciej Womperski; Dariusz Kałka
Journal:  Asian J Androl       Date:  2020 Sep-Oct       Impact factor: 3.285

4.  Association Between Penile Color Doppler Ultrasonography and Cardiorespiratory Fitness in Patients With Vascular Erectile Dysfunction.

Authors:  Maurizio De Rocco Ponce; Marco Vecchiato; Daniel Neunhaeuserer; Francesca Battista; Nicola Caretta; Francesco Savalla; Claudia Favero; Andrea Garolla; Carlo Foresta; Andrea Ermolao
Journal:  Sex Med       Date:  2021-05-08       Impact factor: 2.523

5.  Monitoring functional capacity in heart failure.

Authors:  Massimo F Piepoli; Ilaria Spoletini; Giuseppe Rosano
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.